First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
Xiaotian Zhang(Peking University), Yanhua Chen(Tongji University), Zhenwei Shen, Gang Wang(Spinal Cord Injury BC), Xiao Li(University of Washington), Wangjun Liao(Sun Yat-sen University), Yongquan Shi(National Clinical Research Center for Digestive Diseases), Zishu Wang(Bengbu Medical College), Hongming Pan(Sir Run Run Shaw Hospital), Qingmei Shi, Changlu Hu(Anhui Provincial Hospital), Yanxia Ji, Yongqian Shu(Jiangsu Province Hospital), Yanqiao Zhang(Harbin Medical University), Xiaoyan Lin(Fujian Medical University), Chuangxin Lu(Henan Provincial People's Hospital), Meili Sun(Jinan Central Hospital), Ping Chen(Ningxia Medical University), Qi Wang(Hebei Medical University), Qi Li(Chuxiong Normal University), Tao Zhang, Hongxia Li, Li Zhang(Fourth Hospital of Changsha), Yan Lin, Jiayi Li(First Affiliated Hospital of Xiamen University), Zhong Xie(Zhengzhou University), Yunbo Zhao(Weifang Medical University), Zhanxiong Luo(Liuzhou General Hospital), Jianping Xiong, Dan Zhu(Inner Mongolia Medical University), Sheng Yao(Hebei University of Technology), Jie Luo(Hunan University), Qingxia Fan(First Affiliated Hospital of Zhengzhou University), Yanrong Gao, Ruixing Zhang(Hebei Medical University), Jufeng Wang(Henan Cancer Hospital), Sanyuan Sun(Xuzhou Central Hospital), Jason Yang, Xinhui Yang, Yunpeng Liu, Junye Wang(Sun Yat-sen University), Ting Fu, Yinping Sun, Yanru Xie(Lishui Central Hospital), Yiping Mou(Zhejiang Provincial People's Hospital), Yiye Wan(Jiangxi Provincial Cancer Hospital), Lin Shen(Peking University), Yanhong Deng(Sun Yat-sen University)
Cited by 72
Related Papers
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease
|Journal of Structural Biology|2005|585